Prosetta Biosciences IPO

Prosetta Biosciences is a biotechnology company focused on developing novel small-molecule antiviral therapeutics based on Cell-Free Protein Synthesizing Systems (CFPSS).

Register for Details

For more details on financing and valuation for Prosetta Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Prosetta Biosciences's ticker symbol?

Prosetta Biosciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Prosetta Biosciences's stock price?

The stock price for Prosetta Biosciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Prosetta Biosciences Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
12/31/2015 Series D $31.1MM raised $XXX.XX $XXX.XX
7/15/2012 Series C $15.75MM raised $XXX.XX $XXX.XX
9/15/2008 Series B $7.4MM raised $XXX.XX $XXX.XX
5/18/2007 Series A, AA and AAA $9.39MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Prosetta Biosciences

Forge green plus iconForge green minus icon

What is Prosetta Biosciences funding to date?

Prosetta Biosciences has raised $63.64MM to date.
Forge green plus iconForge green minus icon

When was Prosetta Biosciences founded?

Prosetta Biosciences was founded in 2003.
Forge green plus iconForge green minus icon

Can you invest in Prosetta Biosciences?

Prosetta Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Prosetta Biosciences share pre-IPO?

If you own Prosetta Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Prosetta Biosciences a publicly traded company?

Prosetta Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Prosetta Biosciences in the Healthcare sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$656.14MM
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$705.25MM
Sector
Last Round Est. Valuation
$1.15B
Sector
Last Round Est. Valuation
$1.22B
Sector
Last Round Est. Valuation
$8.45B
Sector
Last Round Est. Valuation
$500MM
Updated on: Jun 12, 2022

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.